| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 07/10/2008 | WO2008083356A1 Substituted triazoles useful as axl inhibitors |
| 07/10/2008 | WO2008083354A1 N3-heteroaryl substituted triazoles and n5-heteroaryl substituted triazoles useful as axl inhibitors |
| 07/10/2008 | WO2008083346A1 Phenazine and quinoxaline substituted amino acids and polypeptides |
| 07/10/2008 | WO2008083341A1 Crystalline forms of solvated ilaprazole |
| 07/10/2008 | WO2008083333A1 Solid state forms of racemic ilaprazole |
| 07/10/2008 | WO2008083319A1 Solid state forms of enantiopure ilaprazole |
| 07/10/2008 | WO2008083238A2 Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders |
| 07/10/2008 | WO2008083124A1 N-substituted-heterocycloalkyloxybenzamide compounds and methods of use |
| 07/10/2008 | WO2008082502A2 Process for preparing 2-amino-5-cyanobenzoic acid derivatives |
| 07/10/2008 | WO2008082488A1 4, 5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections |
| 07/10/2008 | WO2008082487A2 Novel jnk inhibitors |
| 07/10/2008 | WO2008082484A1 4,5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections |
| 07/10/2008 | WO2008082009A2 Fused substituted aminopyrrolidine derivative |
| 07/10/2008 | WO2008081940A1 Gel composition for treating mycosis |
| 07/10/2008 | WO2008081011A1 N-methyl carboxamide derivatives useful as fungicides |
| 07/10/2008 | WO2008080973A1 Substituted oxindole derivatives and their use as vasopressin receptor ligands |
| 07/10/2008 | WO2008080972A1 Substituted oxindole derivative and its use as a vasopressin receptor modulator |
| 07/10/2008 | WO2008080971A1 Substituted oxindole derivative and its use as a vasopressin receptor ligand |
| 07/10/2008 | WO2008080970A1 Substituted oxindole derivative and its use as a vasopressin receptor ligand |
| 07/10/2008 | WO2008080969A1 Carboxamide compounds and their use as calpain inhibitors |
| 07/10/2008 | WO2008080965A2 Hiv inhibiting 5,6-substituted pyrimidines |
| 07/10/2008 | WO2008080964A1 Hiv inhibiting 6-substituted pyrimidines |
| 07/10/2008 | WO2008080938A1 Use 2-substituted pyridines for cancer treatment |
| 07/10/2008 | WO2008080937A1 2-substituted pyrimidines i in therapy |
| 07/10/2008 | WO2008080934A1 Stable s-nitrosothiols, method of synthesis and use |
| 07/10/2008 | WO2008080842A1 Indoles |
| 07/10/2008 | WO2008080511A1 Heteroarylcyclopropanecarboxamides and their use as pharmaceuticals |
| 07/10/2008 | WO2008080504A2 Substituted 1-(3-pyridinyl)pyrazole-4-yl acetic acids, method for the production thereof, and use thereof as herbicides and plant growth regulators |
| 07/10/2008 | WO2008058867A3 Substituted 4-imidazoles |
| 07/10/2008 | WO2008048991A3 Organic compounds |
| 07/10/2008 | WO2008022046B1 Dicer substrate rna peptide conjugates and methods for rna therapeutics |
| 07/10/2008 | US20080167479 Process for preparing vildagliptin |
| 07/10/2008 | US20080167473 Process for the Preparation of Optically Active Derivatives of 2-(2-Pyridylmethylsulfinyl)-Benzimidazole Via Inclusion Complex with 1,1'-Binaphthalene-2, 2'Diol |
| 07/10/2008 | US20080167443 Novel chelating agents and highly luminescent and stable chelates and their use |
| 07/10/2008 | US20080167350 Substituted isoxazoles as fungicides |
| 07/10/2008 | US20080167345 Amide substituted indazoles as poly(ADP-ribose)polymerase(PARP) inhibitors |
| 07/10/2008 | US20080167344 Indoles |
| 07/10/2008 | US20080167342 Heteroaryl-Substituted Amides Comprising An Unsaturated Or Cyclic Linker Group, And Their Use As Pharmaceuticals |
| 07/10/2008 | US20080167341 1H-Benzimidazol-2-yl methyl)-piperidin-3-ylmethyl-(5,6,7,8-tetrahydro-quinolin-8-yl)-amine; fusin and chemokine receptors antagonist/agonist; increase progenitor and/or stem cells in humans; HIV, antiinflammatory agent: rheumatoid arthritis, inflammatory bowel disease |
| 07/10/2008 | US20080167322 Substituted Pyrazoles as Modulators of Chemokine Receptors |
| 07/10/2008 | US20080167321 Administering pyridine, pyrimidine or pyridazine derivatives, e.g., N-Hexyl-2-[4-(5-hexylamino-2-trifluoromethylbenzoyl)piperazin-1-yl]isonicotinamide and 5-[4-(5-Fluoro-2-trifluoromethylbenzoyl)piperazin-1-yl]-N-pentylnicotinamide, to treat Type II diabetes, obesity, fatty liver, and metabolic syndrome |
| 07/10/2008 | US20080167320 Compounds are selective ligands for the dopamine D3 receptor; psychotic or depressive disorders, dyskinesia, essential tremor; 2-{4-[4-(3-trifluoromethylphenyl)piperazin-1-yl]butyl}amino-4-phenylpyridine; neuropsychiatry; drug dependency/abuse |
| 07/10/2008 | US20080167318 Pharmaceutically active pyrrolidine derivatives |
| 07/10/2008 | US20080167316 6-Heteroaryl-1,2,3,4,4A, 10B-Hexahydrophenanthridines as Pde4-Inhibitors for the Treatment of Inflammatory Disorders |
| 07/10/2008 | US20080167310 Syndrome X, antidiabetic agents; hypoglycemic agents;antilipemic agents; artherosclerosis; cardiovascular disorders |
| 07/10/2008 | US20080167301 Novel Hydroxy-6-Heteroarylphenanthridines and Their Use as Pde4 Inhibitors |
| 07/10/2008 | US20080167300 N-(Arylidene)morpholinylpyridinylhydrazine derivatives, e.g., N-{4-[2-(3,4-Dimethoxy-phenyl)-ethoxy]-6-morpholin-4-yl-pyridin-2-yl}-N'-(3-methyl-benzylidene)-hydrazine, are used for treating interleukin-12 overproduction-related disorders including inflammatory diseases |
| 07/10/2008 | US20080167297 Pyrimidine Derivatives for Use as Anticancer Agents |
| 07/10/2008 | US20080167288 Substituted cyclic hydroxamates as lnhibitors of matrix metalloproteinases |
| 07/10/2008 | CA2710051A1 Substituted triazoles useful as axl inhibitors |
| 07/10/2008 | CA2710046A1 N3-heteroaryl substituted triazoles and n5-heteroaryl substituted triazoles useful as axl inhibitors |
| 07/10/2008 | CA2674358A1 Crystalline forms of solvated ilaprazole |
| 07/10/2008 | CA2674347A1 Solid state forms of racemic ilaprazole |
| 07/10/2008 | CA2674237A1 N-substituted-heterocycloalkyloxybenzamide compounds and methods of use |
| 07/10/2008 | CA2674185A1 Hiv inhibiting 5,6-substituted pyrimidines |
| 07/10/2008 | CA2674178A1 Hiv inhibiting 6-substituted pyrimidines |
| 07/10/2008 | CA2674133A1 Indoles |
| 07/10/2008 | CA2673976A1 Gel composition for treating mycosis |
| 07/10/2008 | CA2673934A1 Substituted 1-(3-pyridinyl)pyrazole-4-yl acetic acids, method for the production thereof, and use thereof as herbicides and plant growth regulators |
| 07/10/2008 | CA2673584A1 Substituted oxindole derivatives and their use as vasopressin receptor ligands |
| 07/10/2008 | CA2673580A1 Carboxamide compounds and their use as calpain inhibitors |
| 07/10/2008 | CA2673249A1 4,5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections |
| 07/10/2008 | CA2672940A1 Novel jnk inhibitors |
| 07/10/2008 | CA2671851A1 Phenazine and quinoxaline substituted amino acids and polypeptides |
| 07/09/2008 | EP1942107A1 Compound having triazole ring structure substituted with pyridyl group and organic electroluminescent device |
| 07/09/2008 | EP1942106A1 Therapeutic agents useful for treating pain |
| 07/09/2008 | EP1942104A1 Heteroarylcyclopropanecarboxamides and their use as pharmaceuticals |
| 07/09/2008 | EP1942101A1 Secretase inhibitor |
| 07/09/2008 | EP1941881A1 Dermatitis remedies |
| 07/09/2008 | EP1941872A1 Use of TNF-alpha inhibitors for treating nerve root injury |
| 07/09/2008 | EP1940827A1 Carbamate compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/09/2008 | EP1940826A1 Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/09/2008 | EP1940825A1 Quinazoline derivatives as anticancer agents |
| 07/09/2008 | EP1940824A1 Selected cgrp antagonists method for production and use thereof as medicament |
| 07/09/2008 | EP1940823A2 Substituted 1-amino-phthalzine derivatives, preparation and therapeutic use thereof |
| 07/09/2008 | EP1940822A1 Imidazole derivatives and their use for modulating the gaba-a receptor complex |
| 07/09/2008 | EP1940821A2 Novel vanilloid receptor ligands and their use for producing medicaments |
| 07/09/2008 | EP1940820A1 Midazole-4-carboxamide derivatives for use as cb modulators |
| 07/09/2008 | EP1940819A1 Phosphodiesterase 10 inhibitors |
| 07/09/2008 | EP1940805A1 Benzodiazepine and benzopiperazine analog inhibitors of histone deacetylase |
| 07/09/2008 | EP1940803A1 1,2-diarylimidazoles for use as cbi modulators |
| 07/09/2008 | EP1940802A2 Imidazole compounds for the treatment of neurological disorders |
| 07/09/2008 | EP1940800A1 Novel bicyclic sulfonamides for use as glucocorticoid receptor modulators in the treatment of inflammatory diseases |
| 07/09/2008 | EP1940787A1 Novel ido inhibitors and methods of use thereof |
| 07/09/2008 | EP1940401A2 Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators |
| 07/09/2008 | EP1940394A2 Chemical compounds |
| 07/09/2008 | EP1789041B1 Aryl-pyridine derivatives as 11-beta-hsd1 inhibitors |
| 07/09/2008 | EP1768978B1 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
| 07/09/2008 | EP1761520B1 Kinase inhibitors |
| 07/09/2008 | EP1578744B1 Substituted 4-(4-piperidin-4-yl-piperazin-1-yl)-azepane derivatives and their use as neurokinin antagonists |
| 07/09/2008 | EP1572648B1 3,6-disubstituted azabicyclo (3.1.0)-hexane derivatives as muscarinic receptor antagonists |
| 07/09/2008 | EP1560823B1 4-substituted 1-aminocyclohexane derivatives for utilization as orl1-receptor and mu-opiate receptor ligands |
| 07/09/2008 | EP1474396B9 N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof |
| 07/09/2008 | EP1465863B1 Potassium channel modulators |
| 07/09/2008 | EP1332133B1 Metabotropic glutamate receptor antagonists |
| 07/09/2008 | EP1303490B1 N-oxides as nk1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives |
| 07/09/2008 | EP1220842B1 Cyclic amine compound as ccr5 antagonist |
| 07/09/2008 | EP1058680B1 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives as muscarinic receptor antagonists |
| 07/09/2008 | CN101218234A Phenyl-3-{(3-(1H-pyrrol-2-yl)-[1,2,4]oxadiazol-5-yl]piperidin-1-yl}-methanone derivatives and related compounds as positive allosteric modulators of metabotropic glutamate receptors |
| 07/09/2008 | CN101218231A Novel heterocyclic compounds as positive allosteric modulators of metabotropic glutamate receptors |